Business Development Ally (BD Ally®) helps you identify, evaluate and monetize commercially relevant device and pharmaceutical innovation that can deliver on your funding, launch or growth objectives.
Retained to develop a financial valuation model to better inform decision making associated with development prioritization for a ribonucleic acid replicon drug platform targeting head and neck, cervical and pancreatic cancer.
Crafted business and financial model templates utilized in the assessment and ongoing development of an artificial intelligence and ultrasound platform to diagnose lung pathologies within low to lower-middle income countries.
Enlisted to provide preliminary personal selling effort to determine the commercial viability of an UVC disinfecting robot in clean room manufacturing facilities within the biologic and pharmaceutical industries.
Copyright © 2022 Business Development Ally - All Rights Reserved.